Related Experiment Video

Updated: Oct 8, 2026

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis
00:06

An Oncogenic Hepatocyte-Induced Orthotopic Mouse Model of Hepatocellular Cancer Arising in the Setting of Hepatic Inflammation and Fibrosis

Published on: September 12, 2019

Inhibition of Rb and p53 is insufficient for SV40 T-antigen transformation

K F Sachsenmeier1, J M Pipas

  • 1Department of Biological Sciences, University of Pittsburgh, Pittsburgh, PA 15260, USA.

Virology
|April 21, 2001
PubMed

Insights

SV40 large T-antigen (TAg) inactivation of p53 and pRb is not sufficient for oncogenic transformation. Additional TAg activities, requiring amino acids 137 to 708, are necessary for novel transforming functions.

Area of Science:

  • Molecular Biology
  • Oncology
  • Virology

Background:

  • SV40 large T-antigen (TAg) is crucial for studying cell division and tissue homeostasis.
  • TAg disrupts tumor suppressors pRb and p53, but its sufficiency for oncogenic transformation is unclear.
  • Investigating additional TAg activities beyond p53/pRb inhibition is necessary.

Purpose of the Study:

  • To determine if TAg's inhibition of p53 and pRb is sufficient for oncogenic transformation.
  • To identify if additional TAg activities are required for transformation.
  • To elucidate the specific TAg regions involved in transformation.

Main Methods:

  • Generated cell lines coexpressing TAgN136 (blocks pRb) and a dominant-negative p53 (p53DD).
  • Assessed focus formation and saturation density in engineered cell lines.
  • Utilized a full-length TAg mutant unable to bind p53 to evaluate contact inhibition.

Main Results:

  • Coexpression of TAgN136 and p53DD did not enhance focus formation or saturation density.
  • A TAg mutant lacking p53 binding capability still relieved contact inhibition.
  • These findings indicate a novel transforming activity independent of p53 binding.

Conclusions:

  • TAg's inactivation of p53 and pRb alone is insufficient for oncogenic transformation.
  • A novel transforming activity resides in TAg amino acids 137 to 708.
  • This activity is distinct from TAg's interaction with p53 and pRb.

More Related Videos

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses10:13

Tailoring In Vivo Cytotoxicity Assays to Study Immunodominance in Tumor-specific CD8+ T Cell Responses

Published on: May 6, 2019

Inducible and Reversible Dominant-negative (DN) Protein Inhibition08:35

Inducible and Reversible Dominant-negative (DN) Protein Inhibition

Published on: January 7, 2019

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Negative Regulator Molecules01:23

Negative Regulator Molecules

Positive regulators allow a cell to advance through cell cycle checkpoints. Negative regulators have an equally important role as they terminate a cell’s progression through the cell cycle—or pause it—until the cell meets specific criteria.
The Retinoblastoma Gene01:20

The Retinoblastoma Gene

Tumor suppressor genes are normal genes that can slow down cell division, repair DNA mistakes, or program the cells for apoptosis in case of irreparable damage. Hence, they play an essential role in preventing the proliferation of damaged cells.
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
Inhibition of Cdk Activity02:34

Inhibition of Cdk Activity

The orderly progression of the cell cycle depends on the activation of Cdk protein by binding to its cyclin partner. However, the cell cycle must be restricted when undergoing abnormal changes. Most cancers correlate to the deregulated cell cycle, and since Cdks are a central component of the cell cycle, Cdk inhibitors are extensively studied to develop anticancer agents. For instance, cyclin D associates with several Cdks, such as Cdk 4/6, to form an active complex. The cyclin D-Cdk4/6 complex...
Inhibitors of Virion Maturation and Assembly01:19

Inhibitors of Virion Maturation and Assembly

As part of their replication cycle, certain viruses synthesize long precursor proteins called polyproteins within infected host cells. In human immunodeficiency virus (HIV), two major polyproteins are produced: Gag and Gag-Pol. The Gag polyprotein supplies the structural components of the virus, while Gag-Pol includes essential viral enzymes such as reverse transcriptase, integrase, and protease. After synthesis, these polyproteins move to the host cell membrane, where they assemble into an...
DNA Damage can Stall the Cell Cycle02:36

DNA Damage can Stall the Cell Cycle

In response to DNA damage, cells can pause the cell cycle to assess and repair the breaks. However, the cell must check the DNA at certain critical stages during the cell cycle. If the cell cycle pauses before DNA replication, the cells will contain twice the amount of DNA. On the other hand, if cells arrest after DNA replication but before mitosis, they will contain four times the normal amount of DNA. With a host of specialized proteins at their disposal,cells must use the right protein at...